Melanie Householder
Family · Lincoln, NENPI 1851572317
Payments from drug & device makers
Across 22 payments — averaging $24.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$203
- Mckesson Medical-surgical, Inc.$100
- Mayne Pharma Commercial LLC$82
- Biohaven Pharmaceutical Holding Company Ltd.$36
- Astellas Pharma US Inc$34
- Pfizer$20
- plus $69 from 5 others
What the payments were for
- Speaking & faculty fees$10018%
- Food & beverage$44482%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $203 |
| Mckesson Medical-surgical, Inc. | 1 | $100 |
| Mayne Pharma Commercial LLC | 2 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $34 |
| Pfizer | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Lilly USA, LLC | 1 | $12 |
| GSK | 1 | $12 |
| AstraZeneca | 1 | $12 |
How this compares
$544 in reported general payments places this provider in the 65th percentile of 809 family providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nebivolol Hcl | 15 | $1,092 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $530 |
| Atorvastatin Calcium | 26 | $315 |
| Levothyroxine Sodium | 15 | $265 |
| Fluticasone Propionate | 16 | $251 |
| Pantoprazole Sodium | 14 | $206 |
| Pravastatin Sodium | 13 | $158 |
| Amlodipine Besylate | 25 | $144 |
| Metoprolol Succinate | 18 | $122 |
| Metformin Hcl | 16 | $112 |
| Losartan Potassium | 11 | $90 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 13 | $84 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $74 |
| Potassium Chloride | 12 | $71 |
| Lovastatin | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other family in Lincoln
- Mary MetzLincoln$13K
- Alyson FergusonLincoln$7K
- Mary GladeLincoln$7K
- Colleen CarpenterLincoln$5K
- Melany MurrayLincoln$5K
- Samantha NiceLincoln$5K
- Miranda PollmanLincoln$5K
- Marissa EbelLincoln$5K
- John GrandgenettLincoln$4K
- Chelsy BinkleyLincoln$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.